DK0703980T3 - Intracellulære bindingsproteiner og anvendelser deraf - Google Patents

Intracellulære bindingsproteiner og anvendelser deraf

Info

Publication number
DK0703980T3
DK0703980T3 DK94919711T DK94919711T DK0703980T3 DK 0703980 T3 DK0703980 T3 DK 0703980T3 DK 94919711 T DK94919711 T DK 94919711T DK 94919711 T DK94919711 T DK 94919711T DK 0703980 T3 DK0703980 T3 DK 0703980T3
Authority
DK
Denmark
Prior art keywords
pct
binding proteins
date dec
applications
intracellular binding
Prior art date
Application number
DK94919711T
Other languages
English (en)
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0703980T3 publication Critical patent/DK0703980T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/084—Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1147—Regulatory proteins, e.g. trans-activator of transcription [TAT], rev or vacuolar protein targeting [VPT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK94919711T 1993-06-16 1994-06-15 Intracellulære bindingsproteiner og anvendelser deraf DK0703980T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9307241A FR2706486B1 (fr) 1993-06-16 1993-06-16 Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques.
PCT/FR1994/000714 WO1994029446A2 (fr) 1993-06-16 1994-06-15 Proteines intracellulaires de liaison (pil) et leurs utilisations

Publications (1)

Publication Number Publication Date
DK0703980T3 true DK0703980T3 (da) 2003-05-19

Family

ID=9448183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94919711T DK0703980T3 (da) 1993-06-16 1994-06-15 Intracellulære bindingsproteiner og anvendelser deraf

Country Status (24)

Country Link
US (1) US6159947A (da)
EP (1) EP0703980B1 (da)
JP (1) JP4384260B2 (da)
KR (1) KR100342233B1 (da)
CN (1) CN1076052C (da)
AT (1) ATE231916T1 (da)
AU (1) AU7076394A (da)
BR (1) BR9407512A (da)
CA (1) CA2165458C (da)
CZ (1) CZ289039B6 (da)
DE (1) DE69432075T2 (da)
DK (1) DK0703980T3 (da)
ES (1) ES2191031T3 (da)
FI (1) FI120311B (da)
FR (1) FR2706486B1 (da)
HU (1) HU219138B (da)
NO (1) NO319466B1 (da)
NZ (1) NZ268038A (da)
PL (1) PL180760B1 (da)
RU (1) RU2218400C2 (da)
SK (1) SK285169B6 (da)
UA (1) UA46709C2 (da)
WO (1) WO1994029446A2 (da)
ZA (1) ZA944303B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790633B1 (en) * 1990-04-18 2004-09-14 Michael S. Brown Method of inhibiting a farnesyl transferase enzyme
US8003342B1 (en) 1990-04-18 2011-08-23 Board Of Regents, The University Of Texas System Method for identifying farnesyl transferase inhibitors
FR2724320B1 (fr) 1994-09-13 1996-12-20 Transgene Sa Nouvel implant pour le traitement des maladies acquises
US5518042A (en) * 1994-09-16 1996-05-21 Huyck Licensco, Inc. Papermaker's forming fabric with additional cross machine direction locator and fiber supporting yarns
FR2738151B1 (fr) * 1995-09-04 1997-09-26 Rhone Poulenc Rorer Sa Antagonistes de l'activite oncogenique de la proteine mdm2, et leur utilisation dans le traitement des cancers
US7008776B1 (en) 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
ATE291080T1 (de) 1996-12-06 2005-04-15 Aventis Pharma Inc Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden
FR2758569B1 (fr) * 1997-01-20 1999-04-02 Centre Nat Rech Scient Materiel biologique pour le traitement d'un mammifere par transfert de gene d'anticorps et composition pharmaceutique le concernant
WO2000050089A2 (en) * 1999-02-26 2000-08-31 Mindset Biopharmaceuticals (Usa) Ltd. Regulation of the stability of recombinant proteins and antiboodies
FR2794771B1 (fr) 1999-06-11 2001-08-10 Aventis Pharma Sa Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
GB0018307D0 (en) 2000-07-26 2000-09-13 Aventis Pharm Prod Inc Polypeptides
NZ521786A (en) 2000-03-31 2004-07-30 Aventis Pharma Inc NFIF-14b and NFIF-7a (nuclear factor kappa B inducing factor) polypeptides and nulciec acids and their use in compositions for inhibiting inflammation
US20030104402A1 (en) * 2001-01-23 2003-06-05 University Of Rochester Methods of producing or identifying intrabodies in eukaryotic cells
RU2317330C2 (ru) * 2006-01-16 2008-02-20 Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pcL37, КОДИРУЮЩАЯ ПОЛИПЕПТИД СО СВОЙСТВАМИ ЛЕГКОЙ ЦЕПИ АНТИТЕЛА ЧЕЛОВЕКА ПРОТИВ ВИРУСА ОСПОВАКЦИНЫ, РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pcH37, КОДИРУЮЩАЯ ПОЛИПЕПТИД СО СВОЙСТВАМИ ТЯЖЕЛОЙ ЦЕПИ УКАЗАННОГО АНТИТЕЛА, И ИХ ПРИМЕНЕНИЕ
WO2012162628A2 (en) 2011-05-25 2012-11-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Lipopeptide inhibitors of ras oncoproteins
KR101602876B1 (ko) * 2014-07-22 2016-03-11 아주대학교산학협력단 완전한 이뮤노글로불린 형태의 세포질 침투능을 갖는 항체를 이용하여 세포내 활성화된 ras를 억제하는 방법 및 그의 이용
KR101602870B1 (ko) 2014-07-22 2016-03-21 아주대학교산학협력단 완전한 이뮤노글로불린 형태의 항체를 세포막을 투과하여 세포질에 위치시키는 방법 및 그의 이용
KR102207381B1 (ko) * 2014-10-23 2021-01-27 싱 몰레큘러 메디신, 엘엘씨 세포내 항원에 대해 지향된 단일 도메인 항체
US20180072815A1 (en) 2014-10-23 2018-03-15 Singh Biotechnology, Llc Single Domain Antibodies Directed Against Intracellular Antigens
TWI746473B (zh) 2015-11-02 2021-11-21 美商辛分子醫藥有限公司 針對細胞內抗原之單域抗體
MX2018014554A (es) 2016-05-27 2019-09-09 Orum Therapeutics Inc Anticuerpo penetrante de citosol y uso del mismo.
KR20190143826A (ko) 2018-06-21 2019-12-31 오름테라퓨틱 주식회사 세포/조직 특이적 세포 침투 항체
CN110981943B (zh) * 2019-12-02 2021-08-03 清华大学 多肽及其在制备药物中的用途和药物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
DE3915952A1 (de) * 1989-05-12 1990-12-06 Peter Werner Wirkstoff/medikament/biotechnologisches verfahren zur behandlung von erkrankungen, die mit exo- oder endogenen intrazellulaeren proteinen (onkogene etc.) assoziert sind
EP0556197A4 (en) * 1990-09-25 1994-05-18 Univ Connecticut Prolonging expression of polynucleotides introduced into a cell
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
WO1993007286A1 (en) * 1991-09-30 1993-04-15 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Recombinant immunotoxins
WO1993012232A1 (en) * 1991-12-10 1993-06-24 Dana Farber Cancer Institute Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof
DE69334095T2 (de) * 1992-07-17 2007-04-12 Dana-Farber Cancer Institute, Boston Verfahren zur intrazellulären Bindung von zielgerichteten Molekülen

Also Published As

Publication number Publication date
NO955011D0 (no) 1995-12-11
EP0703980A1 (fr) 1996-04-03
BR9407512A (pt) 1997-01-07
JP4384260B2 (ja) 2009-12-16
NO319466B1 (no) 2005-08-15
PL180760B1 (pl) 2001-04-30
HUT74266A (en) 1996-11-28
SK156895A3 (en) 1996-05-08
DE69432075T2 (de) 2003-09-04
FR2706486B1 (fr) 1995-09-01
FI120311B (fi) 2009-09-15
AU7076394A (en) 1995-01-03
ES2191031T3 (es) 2003-09-01
SK285169B6 (sk) 2006-07-07
CN1076052C (zh) 2001-12-12
WO1994029446A2 (fr) 1994-12-22
US6159947A (en) 2000-12-12
KR100342233B1 (ko) 2002-12-05
DE69432075D1 (de) 2003-03-06
ZA944303B (en) 1995-02-14
FI956057L (fi) 1995-12-15
NZ268038A (en) 1997-12-19
FR2706486A1 (fr) 1994-12-23
EP0703980B1 (fr) 2003-01-29
WO1994029446A3 (fr) 1995-02-02
JPH08511162A (ja) 1996-11-26
UA46709C2 (uk) 2002-06-17
CA2165458C (fr) 2011-05-10
HU219138B (hu) 2001-02-28
NO955011L (no) 1995-12-11
CA2165458A1 (fr) 1994-12-22
HU9503615D0 (en) 1996-02-28
RU2218400C2 (ru) 2003-12-10
PL312213A1 (en) 1996-04-01
FI956057A0 (fi) 1995-12-15
CN1126491A (zh) 1996-07-10
CZ329595A3 (en) 1996-03-13
ATE231916T1 (de) 2003-02-15
CZ289039B6 (cs) 2001-10-17

Similar Documents

Publication Publication Date Title
DK0703980T3 (da) Intracellulære bindingsproteiner og anvendelser deraf
ATE400651T1 (de) Verwendung von grünem fluoreszenzprotein
ATE348175T1 (de) Method eder intrazellularen bindung von zielgerichteten molekülen
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
WO1996039429A3 (en) Serum protein produced exclusively in adipocytes
ATE168130T1 (de) Stabilisierte enzyme und waschmittelzusammensetzungen
ES2181674T3 (es) Dominios de union en las proteinas notch y delta.
AU2894289A (en) Domain-modified constant region antibodies
DK0414870T3 (da) Nitratreduktase som markør for Acremonium Chrysogenum
FI941947A0 (fi) Rekombinantti-core-streptavidiini
DE69836823D1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
ATE262537T1 (de) Proliferationsinhibitor von endothellzellen und dessen verwendung
TW272197B (da)
NO972313D0 (no) Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav
ATE417112T1 (de) Steigerung der immunantwort unter verwendung von zielgerichteten molekülen
AU3347293A (en) Expression signal-peptide-free staphylokinases
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
DK0788549T3 (da) Regulerende nukleinsyresekvenser og anvendelser
KR940008700A (ko) 사람형 모노클로날 항펩티드 항체 및 이것을 코드하는 dna
ATE423211T1 (de) Produktion von proteinen, dafür kodierende plasmide und organismen, die solche plasmide enthalten
ATE307201T1 (de) Srcr domäne-enthaltendes protein
MXPA01011563A (es) Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.
DK0778347T3 (da) Protein med formodede helicase- og ATPase-egenskaber, som binder ATP og nukleinsyre
ATE328088T1 (de) Transketolase-verwandtes protein
PT650523E (pt) Antigene cdw52 recombinante